Trinidad and Tobago · Delayed Price · Currency is TTD Medcorp Statistics
Total Valuation
Medcorp has a market cap or net worth of TTD 312.96 million. The enterprise value is 369.51 million.
| Market Cap | 312.96M |
| Enterprise Value | 369.51M |
Important Dates
The next estimated earnings date is Wednesday, March 31, 2027.
| Earnings Date | Mar 31, 2027 |
| Ex-Dividend Date | Sep 14, 2026 |
Share Statistics
Medcorp has 7.83 million shares outstanding. The number of shares has decreased by -0.42% in one year.
| Current Share Class | 7.83M |
| Shares Outstanding | 7.83M |
| Shares Change (YoY) | -0.42% |
| Shares Change (QoQ) | -2.40% |
| Owned by Insiders (%) | 82.96% |
| Owned by Institutions (%) | n/a |
| Float | 1.33M |
Valuation Ratios
The trailing PE ratio is 8.85.
| PE Ratio | 8.85 |
| Forward PE | n/a |
| PS Ratio | 1.92 |
| PB Ratio | 2.85 |
| P/TBV Ratio | 2.85 |
| P/FCF Ratio | 4.13 |
| P/OCF Ratio | 3.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.00, with an EV/FCF ratio of 4.88.
| EV / Earnings | 10.48 |
| EV / Sales | 2.27 |
| EV / EBITDA | 6.00 |
| EV / EBIT | 8.90 |
| EV / FCF | 4.88 |
Financial Position
The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.85.
| Current Ratio | 4.25 |
| Quick Ratio | 3.71 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 1.64 |
| Debt / FCF | 1.23 |
| Interest Coverage | 6.48 |
Financial Efficiency
Return on equity (ROE) is 33.45% and return on invested capital (ROIC) is 21.62%.
| Return on Equity (ROE) | 33.45% |
| Return on Assets (ROA) | 10.86% |
| Return on Invested Capital (ROIC) | 21.62% |
| Return on Capital Employed (ROCE) | 18.36% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 163.08M |
| Profits Per Employee | 35.26M |
| Employee Count | 1 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 8.30 |
Taxes
In the past 12 months, Medcorp has paid 616,583 in taxes.
| Income Tax | 616,583 |
| Effective Tax Rate | 1.72% |
Stock Price Statistics
The stock price has decreased by -23.13% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -23.13% |
| 50-Day Moving Average | 41.02 |
| 200-Day Moving Average | 42.70 |
| Relative Strength Index (RSI) | 15.76 |
| Average Volume (20 Days) | 116 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medcorp had revenue of TTD 163.08 million and earned 35.26 million in profits. Earnings per share was 4.52.
| Revenue | 163.08M |
| Gross Profit | 89.49M |
| Operating Income | 36.68M |
| Pretax Income | 35.88M |
| Net Income | 35.26M |
| EBITDA | 45.22M |
| EBIT | 36.68M |
| Earnings Per Share (EPS) | 4.52 |
Balance Sheet
The company has 36.50 million in cash and 93.05 million in debt, with a net cash position of -56.55 million or -7.22 per share.
| Cash & Cash Equivalents | 36.50M |
| Total Debt | 93.05M |
| Net Cash | -56.55M |
| Net Cash Per Share | -7.22 |
| Equity (Book Value) | 109.84M |
| Book Value Per Share | 14.07 |
| Working Capital | 54.97M |
Cash Flow
In the last 12 months, operating cash flow was 87.05 million and capital expenditures -11.27 million, giving a free cash flow of 75.77 million.
| Operating Cash Flow | 87.05M |
| Capital Expenditures | -11.27M |
| Depreciation & Amortization | 8.55M |
| Net Borrowing | -12.40M |
| Free Cash Flow | 75.77M |
| FCF Per Share | 9.68 |
Margins
Gross margin is 54.88%, with operating and profit margins of 22.49% and 21.62%.
| Gross Margin | 54.88% |
| Operating Margin | 22.49% |
| Pretax Margin | 22.00% |
| Profit Margin | 21.62% |
| EBITDA Margin | 27.73% |
| EBIT Margin | 22.49% |
| FCF Margin | 46.46% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 5.00%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 5.00% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 66.61% |
| FCF Payout Ratio | 20.67% |
| Buyback Yield | 0.42% |
| Shareholder Yield | 5.43% |
| Earnings Yield | 11.30% |
| FCF Yield | 24.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |